T
TARSUS PHARMACEUTICALS INC
NASDAQ: TARS (Tarsus Pharmaceuticals, Inc.)
最近更新时间: 1小时之前67.20
0.24 (0.36%)
| 前收盘价格 | 66.96 |
| 收盘价格 | 66.32 |
| 成交量 | 671,288 |
| 平均成交量 (3个月) | 610,320 |
| 市值 | 2,859,863,296 |
| 预期市盈率 (P/E Forward) | 106.38 |
| 价格/销量 (P/S) | 5.98 |
| 股市价格/股市净资产 (P/B) | 8.01 |
| 52周波幅 | |
| 利润日期 | 30 Apr 2026 |
| 营业毛利率 | -44.91% |
| 营业利益率 (TTM) | -33.55% |
| 稀释每股收益 (EPS TTM) | -2.70 |
| 季度收入增长率 (YOY) | 183.70% |
| 总债务/股东权益 (D/E MRQ) | 21.13% |
| 流动比率 (MRQ) | 5.57 |
| 营业现金流 (OCF TTM) | -65.89 M |
| 杠杆自由现金流 (LFCF TTM) | -36.41 M |
| 资产报酬率 (ROA TTM) | -16.05% |
| 股东权益报酬率 (ROE TTM) | -33.98% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Tarsus Pharmaceuticals, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.7
| 分析师共识 | 3.0 |
| 内部交易活动 | -3.5 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.70 |
|
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.25% |
| 机构持股比例 | 110.77% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Rtw Investments, Lp | 31 Dec 2025 | 3,335,320 |
| Deep Track Capital, Lp | 31 Dec 2025 | 3,004,034 |
| Paradigm Biocapital Advisors Lp | 31 Dec 2025 | 2,562,154 |
| Jennison Associates Llc | 31 Dec 2025 | 2,230,069 |
| Janus Henderson Group Plc | 31 Dec 2025 | 1,930,325 |
| Tang Capital Management Llc | 31 Dec 2025 | 1,188,624 |
| Driehaus Capital Management Llc | 31 Dec 2025 | 1,172,427 |
| Assenagon Asset Management S.A. | 31 Dec 2025 | 1,127,730 |
| Lord, Abbett & Co. Llc | 31 Dec 2025 | 855,645 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 105.00 (Oppenheimer, 56.25%) | 购买 |
| 中 | 97.50 (45.09%) | |
| 低 | 90.00 (Guggenheim, 33.93%) | 购买 |
| 平均值 | 97.50 (45.09%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 72.65 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 25 Feb 2026 | 90.00 (33.93%) | 购买 | 72.65 |
| Oppenheimer | 25 Feb 2026 | 105.00 (56.25%) | 购买 | 72.65 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| AZAMIAN BOBAK R. | - | 68.26 | -34,603 | -2,360,489 |
| FARROW JEFFREY S | - | 68.26 | -6,430 | -438,798 |
| LIN ELIZABETH YEU | - | 68.26 | -1,144 | -78,067 |
| LINK WILLIAM J PHD | - | 68.90 | -12,500 | -861,250 |
| MOTTIWALA AZIZ | - | 68.26 | -13,056 | -890,969 |
| NEERVANNAN SESHADRI | - | 67.32 | -14,313 | -963,576 |
| WAHL BRYAN | - | 68.26 | -12,440 | -848,932 |
| WHITFIELD DIANNE C. | - | 68.26 | -12,274 | -837,603 |
| 累积净数量 | -106,760 | |||
| 累积净值 ($) | -7,279,684 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 68.12 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| NEERVANNAN SESHADRI | 职员 | 20 Mar 2026 | 自动卖出 (-) | 2,989 | 64.51 | 192,820 |
| AZAMIAN BOBAK R. | 职员 | 19 Mar 2026 | 卖 (-) | 11,964 | 66.75 | 798,597 |
| FARROW JEFFREY S | 职员 | 19 Mar 2026 | 卖 (-) | 2,186 | 66.75 | 145,916 |
| LIN ELIZABETH YEU | 职员 | 19 Mar 2026 | 卖 (-) | 390 | 66.75 | 26,033 |
| MOTTIWALA AZIZ | 职员 | 19 Mar 2026 | 卖 (-) | 4,440 | 66.75 | 296,370 |
| NEERVANNAN SESHADRI | 职员 | 19 Mar 2026 | 卖 (-) | 4,589 | 66.75 | 306,316 |
| WAHL BRYAN | 职员 | 19 Mar 2026 | 卖 (-) | 4,231 | 66.75 | 282,419 |
| WHITFIELD DIANNE C. | 职员 | 19 Mar 2026 | 卖 (-) | 4,174 | 66.75 | 278,615 |
| AZAMIAN BOBAK R. | 职员 | 18 Mar 2026 | 卖 (-) | 11,667 | 68.24 | 796,156 |
| FARROW JEFFREY S | 职员 | 18 Mar 2026 | 卖 (-) | 2,133 | 68.24 | 145,556 |
| LIN ELIZABETH YEU | 职员 | 18 Mar 2026 | 卖 (-) | 379 | 68.24 | 25,863 |
| MOTTIWALA AZIZ | 职员 | 18 Mar 2026 | 卖 (-) | 4,330 | 68.24 | 295,479 |
| NEERVANNAN SESHADRI | 职员 | 18 Mar 2026 | 卖 (-) | 3,610 | 68.24 | 246,346 |
| WAHL BRYAN | 职员 | 18 Mar 2026 | 卖 (-) | 4,125 | 68.24 | 281,490 |
| WHITFIELD DIANNE C. | 职员 | 18 Mar 2026 | 卖 (-) | 4,071 | 68.24 | 277,805 |
| AZAMIAN BOBAK R. | 职员 | 17 Mar 2026 | 卖 (-) | 10,972 | 69.79 | 765,736 |
| FARROW JEFFREY S | 职员 | 17 Mar 2026 | 卖 (-) | 2,111 | 69.79 | 147,327 |
| LIN ELIZABETH YEU | 职员 | 17 Mar 2026 | 卖 (-) | 375 | 69.79 | 26,171 |
| MOTTIWALA AZIZ | 职员 | 17 Mar 2026 | 卖 (-) | 4,286 | 69.79 | 299,120 |
| NEERVANNAN SESHADRI | 职员 | 17 Mar 2026 | 卖 (-) | 3,125 | 69.79 | 218,094 |
| WAHL BRYAN | 职员 | 17 Mar 2026 | 卖 (-) | 4,084 | 69.79 | 285,022 |
| WHITFIELD DIANNE C. | 职员 | 17 Mar 2026 | 卖 (-) | 4,029 | 69.79 | 281,184 |
| LINK WILLIAM J PHD | 董事 | 16 Mar 2026 | 自动卖出 (-) | 12,500 | 68.90 | 861,250 |
| LIN ELIZABETH YEU | 职员 | 15 Mar 2026 | 执行期权 | 2,511 | - | - |
| AZAMIAN BOBAK R. | 职员 | 15 Mar 2026 | 执行期权 | 66,274 | - | - |
| FARROW JEFFREY S | 职员 | 15 Mar 2026 | 执行期权 | 13,042 | - | - |
| MOTTIWALA AZIZ | 职员 | 15 Mar 2026 | 执行期权 | 26,482 | - | - |
| NEERVANNAN SESHADRI | 职员 | 15 Mar 2026 | 执行期权 | 26,287 | - | - |
| WAHL BRYAN | 职员 | 15 Mar 2026 | 执行期权 | 24,236 | - | - |
| WHITFIELD DIANNE C. | 职员 | 15 Mar 2026 | 执行期权 | 23,909 | - | - |
| 显示更多 | ||||||
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合